Skip to main content
. Author manuscript; available in PMC: 2013 Nov 5.
Published in final edited form as: Small. 2012 Jul 6;8(18):10.1002/smll.201200437. doi: 10.1002/smll.201200437

Figure 1.

Figure 1

Theoretical model depicting the role of DEX-P NPs in blocking immune and cytokine related effects in the tumor and normal tissues. DEX will be released intra-and inter-cellularly and be taken up by phagocytes and tumor cells.